INSM Q4 2020 Earnings — Insmed Incorporated Revenue & Financial Results | Market Cap Arena

INSMInsmed Incorporated

$31B

Q4 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$41M-9.4% YoY

Gross Profit

$31M73.8% margin

Operating Income

-$95M-228.3% margin

Net Income

-$102M-246.8% margin

EPS (Diluted)

$-1.00

QoQ Revenue Growth

-5.1%

Cash Flow

Operating Cash Flow

-$67M

Free Cash Flow

-$68M

Stock-Based Comp.

$9M

Balance Sheet

Total Assets

$796M

Total Liabilities

$520M

Stockholders' Equity

$276M

Cash & Equivalents

$533M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$41M	$46M	-9.4%
Gross Profit	$31M	$37M	-17.4%
Operating Income	-$95M	-$47M	-100.8%
Net Income	-$102M	-$53M	-92.9%